Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
08/2012
08/28/2012US8252924 Process for preparing benzomorpholine derivatives by hydrogenating o-nitrophenoxy carbonyl compounds
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252788 Therapeutic compounds
08/28/2012US8252209 Photochromic compounds based on ring opening and closing of an [1,3]oxazine compound
08/28/2012CA2535412C Process for the preparation of n-arylmorpholinones
08/23/2012WO2012110833A2 Fluorescence modulators
08/23/2012WO2012090177A3 Cannabinoid receptor modulators
08/23/2012WO2011154827A3 Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
08/23/2012US20120214953 Phosphorus-containing compounds useful for making halogen-free, ignition-resistant polymers
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214782 New compounds, pharmaceutical compositions and uses thereof
08/21/2012US8247401 P2X3 receptor antagonists for treatment of pain
08/16/2012US20120208804 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
08/16/2012US20120208797 Pyrimidone derivatives
08/16/2012US20120207765 Chemokine receptor antagonists and use thereof
08/15/2012CN102639516A 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives
08/14/2012US8242268 Production of bepromoline
08/14/2012US8242267 Polymorphs of efavirenz
08/14/2012CA2544649C Morpholine derivatives as norepinephrine reuptake inhibitors
08/14/2012CA2531088C Photochromic compounds
08/09/2012WO2012104865A1 N, n- dialkyl -morpholin- 4 - carboxamide compounds as insect repelling agents and a process for their preparation
08/09/2012US20120202995 Process for the preparation of 2-(2-aminoethoxy) ethanol (2aee) and morpholine with 2aee: morpholine >3
08/09/2012US20120202993 Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates
08/09/2012CA2817841A1 1,4 oxazines as bace1 and/or bace2 inhibitors
08/08/2012EP2483255A1 Oxazine derivatives and their use in the treatment of neurological disorders
08/08/2012EP1838296B1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
08/02/2012WO2012101245A1 Polymerizable composition comprising an oxime sulfonate as thermal curing agent
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196813 Glycoside derivative and uses thereof
08/01/2012EP2481732A1 Condensed ring compound and use thereof
08/01/2012CN102617580A Vasopressin V1a Antagonists
08/01/2012CN102617567A Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/01/2012CN102617503A Novel synthetic method of (S)-3-morpholinyl carboxylic acid
07/2012
07/31/2012US8231690 Composition comprising derivatives of phenoxazinones for hair colouring
07/26/2012WO2012098064A1 1,4 oxazines as bace1 and/or bace2 inhibitors
07/26/2012WO2012097511A1 Dmp-266 by cyclisation
07/26/2012WO2012097510A1 Process for preparation of efavirenz by cyclisation
07/26/2012US20120190816 Asymmetric synthesis of peptides
07/26/2012US20120190675 Azaspirohexanones
07/26/2012US20120189492 Fullerene compositions and methods for photochemical purification
07/26/2012CA2819158A1 1,4 oxazines as bace1 and/or bace2 inhibitors
07/25/2012CN102603695A Amino acid-fluorophore compound and application thereof
07/25/2012CN102603665A Synthesis method of 4-(4-aminophenyl)-3-morpholone
07/25/2012CN101921266B 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof
07/19/2012WO2012095803A1 New fluorescent compounds
07/19/2012US20120184540 1,4 oxazines as bace1 and/or bace2 inhibitors
07/19/2012US20120184438 Formulations
07/18/2012CN102596921A Novel compounds
07/18/2012CN102584801A One pot method asymmetric synthesis process of HIV reverse transcriptase inhibitor Efavirenz compound
07/18/2012CN102584738A New technology for synthesizing rivaroxaban intermediate
07/18/2012CN102584736A Method for catalyzing and oxidizing hydroxamic acids
07/18/2012CN102584604A Low-VOC polyamino alcohols
07/18/2012CN101952262B Halogen-free benzoxazine based curable compositions for high TG applications
07/17/2012US8222408 Process for preparing acyl amide compounds
07/17/2012US8222405 Phenylalanine derivatives
07/17/2012US8222247 Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof
07/12/2012WO2012094622A2 Amination of aryl alcohol derivatives
07/12/2012WO2012092873A1 Synthetic rivaroxaban intermediate and preparation method thereof
07/12/2012US20120178925 Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof
07/12/2012US20120178915 Pyrimidine derivatives and analogs, preparation method and use thereof
07/12/2012US20120178747 Compositions and methods for bone formation and remodeling
07/11/2012EP2474531A2 Matrix metalloproteinase inhibitors
07/11/2012EP2473492A1 Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2.1]hept-5-enes
07/11/2012EP2473491A1 Morpholinone compounds as factor ixa inhibitors
07/11/2012EP2473490A1 (thio)morpholine derivatives as s1p modulators
07/11/2012CN102574843A Fused ring analogues of anti-fibrotic agents
07/11/2012CN102574778A Novel biphenyl and phenyl-pyridine amides
07/11/2012CN101646662B Novel prophylactic and/or therapeutic agent for diabetic neuropathy
07/10/2012US8217063 Lactam-substituted dicarboxylic acids and use thereof
07/10/2012CA2469191C [1,2]-oxazine-3,5-diones
07/05/2012WO2012090177A2 Cannabinoid receptor modulators
07/05/2012WO2012064744A3 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
07/05/2012US20120172357 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/04/2012EP2471783A1 Novel polymorphic form of efavirenz
07/04/2012CN1845911B Condensed ring compound and use thereof
07/04/2012CN102548976A (Thio) morpholine derivatives as S1P modulators
07/04/2012CN102532062A Benzoyl urea compound and synthesis method thereof
07/04/2012CN102531813A Process for continuous hydrogenation or hydrogenating amination
07/04/2012CN101898982B Npy y5 antagonists
07/04/2012CN101296912B Theramutein modulators
07/03/2012US8212049 Electronically tuned ligands for asymmetric hydrogenation
07/03/2012CA2568356C Bicyclic heterocycles as hiv integrase inhibitors
06/2012
06/28/2012WO2012088314A1 Bicyclic pkm2 activators
06/28/2012WO2012087720A1 Methods of making diastereomeric organic compounds
06/28/2012US20120165521 Low-voc polyamino alcohols
06/28/2012US20120165276 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
06/28/2012DE112010001630T5 Monomer, Polymerisationsverfahren und Polymer Monomer, polymerization and polymer
06/28/2012CA2822432A1 Bicyclic pkm2 activators
06/27/2012EP2467368A1 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives
06/27/2012EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors
06/27/2012CN102516204A Substituted morpholine and thiomorpholine derivatives
06/27/2012CN102516194A Benzoxazine intermediate and its preparation method
06/27/2012CA2759346A1 Low-voc polyamino alcohols
06/26/2012US8207227 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
06/26/2012US8207167 Aryl-phenyl-sulfonamide-phenylene compounds and their use
06/26/2012US8207164 Oxazine derivatives and their use in the treatment of neurological disorders
06/26/2012US8207163 Compositions, synthesis, and methods of using piperazine based antipsychotic agents
06/26/2012CA2635093C Derivatives of sulindac, use thereof and preparation thereof
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 112